Detection of live Trypanosoma cruzi in tissues of Infected mice by using histochemical stain for β-galactosidase

Infection and Immunity

Volumn 67, Issue 1, 1999, Pages 403-409

  Buckner, Frederick S ^a   Wilson, Aaron J ^a   Van Voorhis, Wesley C ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CHAGAS DISEASE; CONTROLLED STUDY; HISTOCHEMISTRY; HOST CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PARASITE IDENTIFICATION; PARASITOSIS; PRIORITY JOURNAL; STAINING; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; TRYPOMASTIGOTE;

EID: 0032892735     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.1.403-409.1999     Document Type: Article

References (56)

1. Acosta, A. M., and C. A. Santos-Buch. 1984. Autoimmune myocarditis induced by Trypanosoma cruzi. Circulation 71:1255-1261.
2. Ajioka, J., and J. Swindle. 1996. The calmodulin-ubiquitin (CUB) genes of Trypanosoma cruzi are essential for parasite viability. Mol. Biochem. Parasitol. 78:217-225.
3. Andrade, S. G., J. B. Magalhaes, and A. L. Pontes. 1985. Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types. Bull. W. H. O. 63:721-726.
4. Andrade, V., C. Brodskyn, and S. G. Andrade. 1983. Correlation between isoenzyme patterns and biological behaviour of different strains of Trypanosoma cruzi. Trans. R. Soc. Trop. Med. Hyg. 77:796-799.
5. Aznar, C., P. Lopez-Bergami, S. Brandariz, C. Mariette, P. Liegeard, M. d. C. de Deus Alves, E. L. Barreiro, R. Carrasco, S. Lafon, D. Kaplan, H. Miguez, C. Camacho, G. Levitus, J. M. Levin, and M. Hontebeyrie. 1995. Prevalence of anti-R-13 antibodies in human Trypanosoma cruzi infection. FEMS Immunol. Med. Microbiol. 12:231-238.
6. Bellotti, G., E. A. Bocchi, A. V. de Moraes, M. L. Higuchi, M. Barbero-Marcial, E. Sosa, A. Esteves-Filho, R. Kalil, R. Weiss, A. Jatene, and F. Pileggi. 1996. In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease. Am. Heart J. 131:301-307.
7. Ben Younes-Chennoufi, A., M. Hontebeyrie-Joskowicz, V. Tricottet, H. Eisen, M. Reynes, and G. Said. 1988. Persistence of Trypanosoma cruzi antigens in the inflammatory lesions of chronically infected mice. Trans. R. Soc. Trop. Med. Hyg. 82:77-83.
8. Bestetti, R. B. 1996. Role of parasites in the pathogenesis of Chagas' cardiomyopathy. Lancet 347:913-914.
9. Bice, D. E., and R. Zeledon. 1970. Comparison of infectivity of strains of Trypanosoma cruzi (Chagas, 1909). J. Parasitol. 56:663-670.
10. Brandariz, S., A. Schijman, C. Vigliano, P. Arteman, R. Viotti, C. Beldjord, and M. J. Levin. 1995. Detection of parasite DNA in Chagas' heart disease. Lancet 346:1370-1371.
11. Buckner, F. S., C. L. M. J. Verlinde, A. C. La Flamme, and W. C. Van Voorhis. 1996. Efficient techniques for screening drugs for activity against Trypanosoma cruzi using parasites expressing β-galactosidase. Antimicrob. Agents Chemother. 40:2592-2597.
12. Buckner, F. S., B. T. Wipke, and W. C. Van Voorhis. 1997. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes. Eur. J. Immunol. 27:2541-2548.
13. Cunha-Neto, E., V. Coelho, L. Guilherme, A. Fiorelli, N. Stolf, and J. Kalil. 1996. Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' disease cardiomyopathy patient. J. Clin. Invest. 98:1709-1712.
14. de Diego, J. A., J. del Rey, R. Mayer, and C. Gamallo. 1991. A comparative pathological study of three strains of Trypanosoma cruzi in an experimental model. Histol. Histopathol. 6:199-206.
15. Eisen, H., K. Petry, and W. C. Van Voorhis. 1990. The origin of autoimmune pathology associated with Trypanosoma cruzi infection, p. 91-103. In L. H. T. Van Der Ploeg, C. R. Cantor, and H. J. Voegel (ed.), Immune recognition and evasion: molecular aspects of host-parasite interaction. Academic Press, Ltd., London, United Kingdom.
16. Elies, R., I. Ferrari, G. Wallukat, D. Lebesgue, P. Chiale, M. Elizari, M. Rosenbaum, J. Hoebeke, and M. J. Levin. 1996. Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas' disease. J. Immunol. 157:4203-4211.
17. Factor, S. M., S. Cho, M. Wittner, and H. B. Tanowitz. 1985. Abnormalities of the coronary microcirculation in acute murine Chagas' disease. Am. J. Trop. Med. Hyg. 34:246-253.
18. Ferrari, I., M. J. Levin, G. Wallukat, R. Elies, D. Lebesgue, P. Chiale, M. Elizari, M. Rosenbaum, and J. Hoebeke. 1995. Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human β1-adrenergic receptor. J. Exp. Med. 182: 59-65.
19. Hanson, W. L., and E. L. Roberson. 1974. Density of parasites in various organs and the relation to numbers of trypomastigotes in the blood during acute infections of Trypanosoma cruzi in mice. J. Protozool. 21:512-517.
20. Higuchi, M. L., T. De Brito, M. M. Reis, A. Barbosa, G. Bellotti, A. C. Pereira-Barreto, and F. Pilleggi. 1993. Correlation between Trypanosoma cruzi parasitism and myocardial inflammation infiltrate in human chronic chagasic myocarditis: light microscopy and immunohistochemical findings. Cardiovasc. Pathol. 2:101-106.
21. Hudson, L. 1985. Autoimmune phenomena in chronic chagasic cardiopathy. Parasitol. Today 1:6-9.
22. Jones, E. M., D. G. Colley, S. Tostes, E. Reis Lopes, C. L. Vnencak-Jones, and T. L. McCurley. 1993. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human Chagasic cardiomyopathy. Am. J. Trop. Med. Hyg. 48:348-357.
23. Kalil, J., and E. Cunha-Neto. 1996. Autoimmunity in Chagas disease cardiomyopathy: fulfilling the criteria at last? Parasitol. Today 12:396-399.
24. Kaplan, D., I. Ferrari, P. L. Bergami, E. Mahler, G. Levitus, P. Chiale, J. Hoebeke, M.H.V. Van Regenmortel, and M.J. Levin. 1997. Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus. Proc. Natl. Acad. Sci. USA 94:10301-10306.
25. Khoury, E. L., and K. L. Fields. 1980. Chagas' disease and autoimmunity. Lancet i:1088.
26. Khoury, E. L., V. Ritacco, P. M. Cossio, R. P. Laguens, A. Szarfman, C. Diez, and R. M. Arana. 1979. Circulating antibodies to peripheral nerve in American trypanosomiasis (Chagas' disease). Clin. Exp. Immunol. 36:8-15.
27. Kierszenbaum, F. 1985. Is there autoimmunity in Chagas disease? Parasitol. Today 1:4-6.
28. Kierszenbaum, F. 1996. Chronic chagasic tissue lesions in the absence of Trypanosoma cruzi: a proposed mechanism. Parasitol. Today 12:414-415.
29. Koberle, F. 1968. Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv. Parasitol. 6:63-116.
30. Laranja, F. S., E. Dias, G. Nobrega, and A. Miranda. 1956. Chagas' disease: a clinical, epidemiological, and pathologic study Circulation 14:1035-1060.
31. Lauria-Pires, L., and A. R. Teixeira. 1996. Virulence and pathogenecity associated with diversity of Trypanosoma cruzi stocks and clones derived from Chagas' disease patients. Am. J. Trop. Med. Hyg. 55:304-310.
32. Lenzi, H. L., D. N. Oliveira, M. T. Lima, and C. R. Gattass. 1996. Trypanosoma cruzi: paninfectivity of CL strain during murine acute infection. Exp. Parasitol. 84:16-27.
33. Levin, M. J. 1991. Molecular mimicry and Chagas' heart disease: high anti-R-13 autoantibody levels are markers of severe Chagas heart complaint. Res. Immunol. 142:157-159.
34. Levin, M. J. 1996. In chronic Chagas heart disease, don't forget the parasite. Parasitol. Today 12:415-416.
35. Lima, M. T., H. L. Lenzi, and C. R. Gattass. 1995. Negative tissue parasitism in mice injected with a noninfective clone of Trypanosoma cruzi. Parasitol. Res. 81:6-12.
36. Lin, W.-C., and L. A. Culp. 1992. Altered establishment/clearance mechanisms during experimental micrometastasis with live and/or disabled bacterial lacZ-tagged tumor cells. Invasion Metastasis 12:197-209.
37. Melo, R. C., and Z. Brener. 1978. Tissue tropism of different Trypanosoma cruzi strains. J. Parasitol. 64:475-482.
38. Mendelsohn, C., E. Ruberte, M. LeMeur, G. Morriss-Kay, and P. Chambon. 1991. Developmental analysis of the retinoic acid-inducible RAR-β2 promoter in transgenic animals. Development 113:723-734.
39. Mirkin, G. A., M. Jones, O. P. Sanz, R. Rev, R. E. P. Sica, and S. M. Gonzalez Cappa. 1994. Experimental Chagas' disease: electrophysiology and cell composition of the neuromyopathic inflammatory lesions in mice infected with a myotropic and a pantropic strain of Trypanosoma cruzi. Clin. Immunol. Immunopathol. 73:69-79.
40. Morales, M. C., R. L. Cardoni, M. T. Rimoldi, M. Esteva, and J. Milei. 1987. Heart damage comparing three strains of mice chronically infected with Trypanosoma cruzi. Medicina (Buenos Aires) 47:493-499.
41. Mott, K. E., and J. W. C. Hagstrom. 1965. The pathologic lesions of the cardiac autonomic nervous system in chronic Chagas' myocarditis. Circulation 31:273-286.
42. Oliveira, J. S. M., M. dos Santos, G. Muccillo, and A. L. Ferreira. 1985. Increased capacity of the coronary arteries in chronic Chagas' heart disease: further support for the neurogenic pathogenesis concept. Am. Heart J. 109:304-308.
43. Petry, K., E. Nudelman, H. Eisen, and S. Hakomori. 1988. Sulfated lipids represent common antigens on the surface of Trypanosoma cruzi and mammalian tissues. Mol. Biochem. Parasitol. 30:113-122.
44. Petry, K., P. Voisin, and T. Baltz. 1987. Complex lipids as common antigens to Trypanosoma cruzi, T. dionisii. T. vespertilionis and nervous tissue (astrocytes, neurons). Acta Trop. 44:381-386.
45. Postan, M., A. W. Cheever, J. A. Dvorak, and J. P. McDaniel. 1986. A histopathological analysis of the course of myocarditis in C3H/He mice infected with Trypanosoma cruzi clone Sylvio-X10/4. Trans. R. Soc. Trop. Med. Hyg. 80:50-55.
46. Prata, A. 1994. Chagas' disease. Infect. Dis. Clin. North Am. 8:61-76.
47. Rocken, M., and E. M. Shevach. 1993. Do parasitic infections break T-cell tolerance and trigger autoimmune disease. Parasitol. Today 9:377-380.
48. Said, G., M. Joskowicz, A. A. Barreira, and H. Eisen. 1985. Neuropathy associated with experimental Chagas' disease. Ann. Neurol. 18:676-683.
49. Santos-Buch, C. A., A. M. Acosta, H. J. Zweerink, M. Sadigursky, O. F. Andersen, B. F. von Kreuter, C. I. Brodskyn, C. Sadigursky, and R. J. Cody. 1985. Primary muscle disease: definition of a 25-kDa polypeptide myopathic specific Chagas antigen. Clin. Immunol. Immunopathol. 37:334-350.
50. Snary, D., J. E. Flint, J. N. Wood, M. T. Scott, M. D. Chapman, J. Dodd, T. M. Jessell, and M. A. Miles. 1983. A monoclonal antibody with specificity for Trypanosoma cruzi, central and peripheral neurones and glia. Clin. Exp. Immunol. 54:617-624.
51. Tarleton, R. L., L. Zhang, and M. O. Downs. 1997. "Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue. Proc. Natl. Acad. Sci. USA 94:3932-3937.
52. Tibbetts, R. S., T. S. McCormick, E. C. Rowland, S. D. Miller, and D. M. Engman. 1994. Cardiac antigen-specific autoantibody production is associated with cardiomyopathy in Trypanasoma cruzi-infected mice. J. Immunol. 152:1493-1499.
53. Trover, H. 1980. Principles and techniques of histochemistry. Little, Brown & Co., Boston, Mass.
54. Van Voorhis, W. C., and H. Eisen. 1989. FL-160: a surface antigen of Trypanosoma cruzi that mimics mammalian nervous tissue. J. Exp. Med. 169:641-652.
55. Wood, J. N., L. Hudson, T. M. Jessell, and M. Yamamoto. 1982. A monoclonal antibody defining antigenic determinants on subpopulations of mammalian neurones and Trypanosoma cruzi parasites. Nature 296:34-38.
56. World Health Organization. 1991. Control of Chagas' disease. W. H. O. Tech. Rep. Ser. 811:1-93.